5 latest FDA approvals

Here are the five latest drugs or medical devices approved by the FDA since June 15:

Advertisement

1. Qbrexza is a topical cloth used to treat primary axillary hyperhidrosis, or excessive armpit sweating.

2. Epidiolex is the first cannabis-based drug approved to treat seizures linked to Lennox-Gastaut syndrome or Dravet syndrome.

3. Braftovi and Mektovi is a combination therapy used to treat advanced melanoma in patients with a specific gene mutation.

4. The Eversense CGM system is the first continuous glucose monitoring system that includes a fully implantable sensor to detect glucose.

5. Advisor Pro is a decision support software for Type 1 diabetes.

More articles on supply chain: 

Here’s how billions of industry dollars are flowing through these 5 drug, device companies
Next generation freight management includes courier services
Shingles vaccine shortage hits US

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

From fragmentation to operational flow: Solving the healthcare workforce puzzle

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenters: Dr. Pat Hunt, QGendaAndrea Daugherty, MHA, CISSP, CHCIO, CDH-E, Arrowhead Regional Medical CenterElizabeth Lindsay-Wood, MBA, CHCIO, CDH-E, Moffitt Cancer CenterDeb Muro, El Camino HealthJohn Tejeda, D.H.A., MLS, MPAS, DFAAPA, LSSBB, FACHE, Vascular and Neuroscience Institute

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.